AC Immune and J&J Advance Tau-Targeting Alzheimer’s Vaccine
Encouraging Early Efficacy Signs
Executive Summary
AC Immune has seen two big disappointments in its Alzheimer’s pipeline this year, but its partner Johnson & Johnson has put its faith in a novel vaccine-like approach to targeting the disease.